RQM

RQM+™ Appoints Eric Pauls as Chief Customer Officer

Retrieved on: 
Wednesday, October 25, 2023

RQM+, a global leader in MedTech services, today announced the appointment of Eric Pauls as chief customer officer, a newly-created senior executive role.

Key Points: 
  • RQM+, a global leader in MedTech services, today announced the appointment of Eric Pauls as chief customer officer, a newly-created senior executive role.
  • With a focus on customer experience and satisfaction, Pauls will steer the company’s global commercialization team, ensuring an alignment between organizational objectives and customer needs.
  • "I'm thrilled to join the RQM+ team and to focus on creating growing value for our customers," said Pauls.
  • "We are incredibly excited to welcome Eric as our new chief customer officer,” said CEO Margaret Keegan.

RQM+™ Acquires Germany Based CRO Kottmann

Retrieved on: 
Monday, August 28, 2023

RQM+, a global leader in MedTech services, announces its acquisition of CRO Kottmann, a premier contract research organization (CRO) renowned for its excellent customer service, scientific clinical research and quality in the key market of Germany.

Key Points: 
  • RQM+, a global leader in MedTech services, announces its acquisition of CRO Kottmann, a premier contract research organization (CRO) renowned for its excellent customer service, scientific clinical research and quality in the key market of Germany.
  • The integration of CRO Kottmann enhances RQM+’s existing geographical footprint in global operations as well as ensures comprehensive end-to-end support for clients, from pre-clinical phases to product commercialization.
  • The addition of CRO Kottmann further expands RQM+'s rapidly growing business as a leading MedTech CRO, driving both existing and new clients’ innovations into pivotal markets.
  • Going forward, our clients can continue using our services to conduct global studies worldwide,” said Tanja Kottmann MD, CEO of CRO Kottmann.

RQM+™ Selects THREAD to Power New Medical Device Research Offering

Retrieved on: 
Tuesday, July 25, 2023

RQM+, the world’s leading MedTech service provider, and THREAD, a leading decentralized research and eCOA provider, today announced the launch of a strategic partnership designed to transform the landscape of MedTech research.

Key Points: 
  • RQM+, the world’s leading MedTech service provider, and THREAD, a leading decentralized research and eCOA provider, today announced the launch of a strategic partnership designed to transform the landscape of MedTech research.
  • This partnership will engage THREAD’s technology across RQM+’s portfolio of medical devices, diagnostic products, and digital therapies to support manufacturers with accelerating research and bringing new products to market faster.
  • “Our strategic partnership enables MedTech clinical research, manufacturers, sites, and patients to unlock the potential for personalized breakthroughs and a future of targeted therapies.
  • “We are excited RQM+ selected THREAD as its partner to enable its new offering, which aligns with our mission to advance research for everyone, everywhere.”

RQM+™ Launches Fern.ai™

Retrieved on: 
Wednesday, June 14, 2023

“Fern.ai empowers clinical, quality and regulatory affairs professionals to focus on quality by automating laborious and frustrating tasks through its human-in-the-loop AI technology,” said RQM+ CEO Margaret Keegan.

Key Points: 
  • “Fern.ai empowers clinical, quality and regulatory affairs professionals to focus on quality by automating laborious and frustrating tasks through its human-in-the-loop AI technology,” said RQM+ CEO Margaret Keegan.
  • “We refer to Fern.ai as human-in-the-loop AI technology because the platform empowers the user by providing recommendations,” said Chief Digital and Technology Officer Alaric Jackson.
  • The judgment and expertise of a highly skilled regulatory professional is irreplaceable and critical to achieve a successful outcome.
  • For more information, visit Fern.ai or the Fern.ai booth at MedTech Summit in Brussels from June 19-23.

RQM+™ Acquires Libra Medical

Retrieved on: 
Wednesday, May 10, 2023

RQM+, the world’s leading MedTech service provider, today announced the acquisition of Libra Medical, a full-service contract research organization (CRO) that specializes in early-stage clinical trials.

Key Points: 
  • RQM+, the world’s leading MedTech service provider, today announced the acquisition of Libra Medical, a full-service contract research organization (CRO) that specializes in early-stage clinical trials.
  • Founded in 2007, Libra Medical provides regulatory affairs, clinical operations and quality assurance services to companies that develop complex medical devices and diagnostics products.
  • We are honored to have Dr. Tay, the founder of Libra Medical, join RQM+ to continue the strong relationships she has established with the early-stage MedTech community and the FDA.”
    With more than 20 years of MedTech expertise, Libra Medical CEO Sew-Wah Tay was the vice president of regulatory and clinical affairs at American Medical Systems (AMS).
  • She also served in leadership roles at multiple MedTech startups, St. Jude Medical and Boston Scientific.

RQM+ Appoints Steven Pilewski as Lab Services Chief Operating Officer

Retrieved on: 
Tuesday, April 25, 2023

RQM+, the world’s leading MedTech service provider, today announced the appointment of Steven Pilewski as chief operating officer for its lab services business unit, which provides chemical characterization and complex product deformulation, as well as contaminant and failure investigations, to MedTech manufacturers.

Key Points: 
  • RQM+, the world’s leading MedTech service provider, today announced the appointment of Steven Pilewski as chief operating officer for its lab services business unit, which provides chemical characterization and complex product deformulation, as well as contaminant and failure investigations, to MedTech manufacturers.
  • View the full release here: https://www.businesswire.com/news/home/20230425005992/en/
    RQM+ Lab Services Chief Operating Officer, Steven Pilewski (Photo: Business Wire)
    With more than 30 years of MedTech and pharma expertise, Pilewski most recently served as vice president of PPD Laboratories’ Good Manufacturing Practices (GMP) lab, which is a division of Thermo Fisher Scientific.
  • When he began his career at PPD 24 years ago, the GMP lab was a small business with only 50 employees.
  • “Steve is an excellent fit to lead our lab services business,” said CEO Margaret Keegan.

RQM+ Appoints Denise Wocko as Head of Global Client Portfolio Management

Retrieved on: 
Thursday, April 6, 2023

RQM+, the world’s leading MedTech service provider, today announced the appointment of Denise Wocko as head of global client portfolio management.

Key Points: 
  • RQM+, the world’s leading MedTech service provider, today announced the appointment of Denise Wocko as head of global client portfolio management.
  • View the full release here: https://www.businesswire.com/news/home/20230406005546/en/
    Denise Wocko, RQM+ Head of Global Client Portfolio Management (Photo: Business Wire)
    “We have an incredible opportunity to reduce the risk of clients who have trusted us with managing their regulatory and quality processes for 40 years by helping them navigate each critical step of their product’s journey,” said Wocko.
  • Our clients have asked us to integrate regulatory, clinical, biocompatibility and market access disciplines to give them efficient, end-to-end support.
  • Her experience spans the MedTech, pharmaceutical and biotech industries, as well as with the contract research organizations (CROs) that serve them.

RQM+ Acquires Giotto Compliance

Retrieved on: 
Thursday, February 9, 2023

RQM+, the world’s leading MedTech service provider, today announced the acquisition of Giotto Compliance from Giotto.ai.

Key Points: 
  • RQM+, the world’s leading MedTech service provider, today announced the acquisition of Giotto Compliance from Giotto.ai.
  • Giotto Compliance is a global, all-in-one artificial intelligence (AI) platform designed to increase the efficiency and effectiveness of regulatory reports and filings across the product development lifecycle for medical device and in vitro diagnostics manufacturers.
  • “We have only begun to scratch the surface of what can be achieved by integrating Giotto Compliance AI technology throughout our consulting, clinical trials, laboratory and reimbursement services,” said RQM+ CEO Margaret Keegan.
  • He will expand the capabilities of Giotto Compliance to enhance our current services as well as offer a standalone solution that can be leveraged to streamline regulatory document development while maintaining compliance with global regulations.”
    Giotto Compliance will operate as an independent RQM+ business unit and serve its growing customer base.

Harris Williams Advises Jordi Labs on its Sale to RQM+

Retrieved on: 
Wednesday, September 7, 2022

Harris Williams , a global investment bank specializing in M&A advisory services, announces it advised Jordi Labs on its sale to RQM+, a portfolio company of Linden Capital Partners (Linden).

Key Points: 
  • Harris Williams , a global investment bank specializing in M&A advisory services, announces it advised Jordi Labs on its sale to RQM+, a portfolio company of Linden Capital Partners (Linden).
  • Harris Williams has a track record of representing best-in-class, market-leading businesses, like Jordi Labs, that provide mission critical services to medical device manufacturers.
  • It was a pleasure working with President Dr. Mark Jordi, Vice President Patrick Burke and the rest of the Jordi Labs team, added Nick Owens, a director at Harris Williams.
  • Harris Williams is a trade name under which Harris Williams LLC, Harris Williams & Co. Ltd and Harris Williams & Co. Corporate Finance Advisors GmbH conduct business.

Notox Retains RQM+ to Assist with Regulatory Filing and USFDA Approval Process

Retrieved on: 
Wednesday, May 19, 2021

b'Richmond Hill, Ontario--(Newsfile Corp. - May 18, 2021) - Notox Technologies Corp. (OTC: NTOX) ("Notox" or the "Company") is pleased to announce that it has retained RQM+, a global consulting agency with U.S. headquarters, to assist Notox with the Company\'s regulatory strategy and filing needs.

Key Points: 
  • b'Richmond Hill, Ontario--(Newsfile Corp. - May 18, 2021) - Notox Technologies Corp. (OTC: NTOX) ("Notox" or the "Company") is pleased to announce that it has retained RQM+, a global consulting agency with U.S. headquarters, to assist Notox with the Company\'s regulatory strategy and filing needs.
  • Finding the right group to lead us through this phase of the process is paramount for all our stakeholders.
  • They deliver transformative solutions by providing an unrivaled collective expertise, fueled by passion for client success.
  • RQM+ experts are collaborative, laser-focused on client needs, and committed to delivering high value solutions that exceed expectations.